GLP injections for weight loss
- • Myweightloss Centre members are 4.5x more likely to achieve significant weight loss
- • Average 20% weight loss in 12 months
- • Available in 6 different strengths
- • Starting from £189 per month
What is Mounjaro?
Mounjaro is a medication that encourages weight loss through the combined action of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) agonists.
These hormones work to reduce cravings, make you feel fuller for longer and improve blood sugar levels while also aiding fat loss and preventing fat gain.
The active ingredient in Mounjaro, called tirzepatide, is the first dual GLP-1 and GIP receptor agonist and, according to clinical trials, is the most effective weight loss treatment currently available, with an average of 20.9% body weight loss.
How Mounjaro works
Our clinically proven treatment with Mounjaro targets the body's metabolic patterns, helping patients lose weight and keep it off.
Slows digestion
Slows digestion and the time it takes to empty the stomach
Reduces appetite
Reduces appetite and keeps you feeling fuller for longer
Improves fat regulation
Decreases sugar production in the liver, helping to improve fat regulation
Regulates blood sugar
Regulates blood sugar levels and increases insulin efficiency
How much weight can I lose with Mounjaro?
The weight loss outcomes experienced in clinical trials of Mounjaro are impressive.
A 2022 study of over 2,500 people found that those using GLP-1/GIP treatment lost up to 20.9% body weight after 72 weeks.
Mounjaro vs Wegovy
Compare the two leading weight loss treatments
Learn More About Mounjaro
Watch our comprehensive guide to weight loss treatment
🎥 Coming Soon
Frequently Asked Questions
Using Mounjaro
Mounjaro is administered as a weekly subcutaneous injection. Your healthcare provider will show you how to properly inject the medication, typically in your thigh, abdomen, or upper arm.
Common side effects include nausea, vomiting, diarrhea, and decreased appetite. These typically improve as your body adjusts to the medication.
Most patients begin to see weight loss within the first few weeks, with significant results typically visible after 3-6 months of consistent use.
Using Wegovy
Wegovy contains semaglutide and targets only GLP-1 receptors, while Mounjaro contains tirzepatide and targets both GLP-1 and GIP receptors, potentially offering greater weight loss benefits.
Yes, you can switch between medications under medical supervision. Your healthcare provider will guide you through the transition process and adjust dosing as needed.
The choice between Mounjaro and Wegovy depends on your individual health profile, weight loss goals, and medical history. Consult with our healthcare team to determine the best option for you.
Ready to Start Your Weight Loss Journey?
Take the first step towards a healthier you with our proven weight loss treatments.
Book Consultation